SENATE BILL No. 1131

 

 

November 6, 2014, Introduced by Senator JONES and referred to the Committee on Judiciary.

 

 

 

      A bill to amend 1978 PA 368, entitled

 

"Public health code,"

 

by amending sections 7214 and 7216 (MCL 333.7214 and 333.7216),

 

section 7214 as amended by 2013 PA 268 and section 7216 as

 

amended by 1999 PA 42.

 

THE PEOPLE OF THE STATE OF MICHIGAN ENACT:

 

 1        Sec. 7214. The following controlled substances are included

 

 2  in schedule 2:

 

 3        (a) Any of the following substances, except those narcotic

 

 4  drugs listed in other schedules, whether produced directly or

 

 5  indirectly by extraction from substances of vegetable origin, or

 

 6  independently by means of chemical synthesis, or by combination

 


 1  of extraction and chemical synthesis:

 

 2        (i) Opium and opiate, and any salt, compound, derivative, or

 

 3  preparation of opium or opiate excluding nalaxone and its salts,

 

 4  and excluding naltrexone and its salts, but including the

 

 5  following:

 

 

6

          Raw opium                    Etorphine hydrochloride

7

          Opium extracts               Hydrocodone

8

          Opium Fluid-extracts         Hydromorphone

9

          Powdered opium               Metopon

10

          Granulated opium             Morphine

11

          Tincture of opium            Oxycodone

12

          Codeine                      Oxymorphone

13

          Ethylmorphine                Thebaine

 

 

14        (ii) A salt, compound, derivative, or preparation thereof

 

15  which that is chemically equivalent to or identical with a

 

16  substance referred to in this subdivision, except that these

 

17  substances do not include the isoquinoline alkaloids of opium.

 

18        (iii) Opium poppy, poppy straw, and concentrate of poppy

 

19  straw, the crude extract of poppy straw in either liquid, solid,

 

20  or powder form, which that contains the phenanthrene alkaloids of

 

21  the opium poppy.

 

22        (iv) Coca leaves and any salt, compound, derivative, or

 

23  preparation thereof which that is chemically equivalent to or

 

24  identical with any of these substances, except that the

 

25  substances do not include decocainized coca leaves or extraction

 

26  of coca leaves which extractions do not contain cocaine or

 


 1  ecgonine. The substances include cocaine, its salts,

 

 2  stereoisomers, and salts of stereoisomers when if the existence

 

 3  of the salts, stereoisomers, and salts of stereoisomers is

 

 4  possible within the specific chemical designation.

 

 5        (b) Any of the following opiates, including their isomers,

 

 6  esters, ethers, salts, and salts of isomers, when if the

 

 7  existence of these isomers, esters, ethers, and salts is possible

 

 8  within the specific chemical designation:

 

 

9

          Alphaprodine                 Fentanyl

10

          Anileridine                  Isomethadone

11

          Bezitramide                  Levomethorphan

12

          Dihydrocodeine               Levorphanol

13

          Diphenoxylate                Metazocine

14

 

15

                           Methadone

16

Methadone-Intermediate, 4-cyano-2dimethylamino-4, 4-diphenyl butane

17

Moramide-Intermediate, 2-methyl-3-morpholino-1,

18

1-diphenylpropane-carboxylic acid

19

 

20

                           Pethidine

21

Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine

22

Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

23

Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-

24

carboxylic acid

25

 

26

          Phenazocine                  Racemethorphan

27

          Piminodine                   Racemorphan

 

 


 1        (c) Unless listed in another schedule, any material,

 

 2  compound, mixture, or preparation which that contains any

 

 3  quantity of the following substances having potential for abuse

 

 4  associated with a stimulant effect on the nervous system:

 

 5        (i) Amphetamine, its salts, optical isomers, and salts of its

 

 6  optical isomers.

 

 7        (ii) Any substance which that contains any quantity of

 

 8  methamphetamine, including its salts, stereoisomers, and salts of

 

 9  stereoisomers.

 

10        (iii) Phenmetrazine and its salts.

 

11        (iv) Methylphenidate and its salts.

 

12        (d) Any material, compound, mixture, or preparation,

 

13  including its salts, isomers, and salts of isomers when if the

 

14  existence of the salts, isomers, and salts of isomers is possible

 

15  within the specific chemical designation as listed in schedule 2,

 

16  which that contains any quantity of the following substances

 

17  having a potential for abuse associated with the depressant

 

18  effect on the central nervous system: methaqualone, amobarbital,

 

19  pentobarbital, or secobarbital; or, any compound, mixture, or

 

20  preparation containing amobarbital, secobarbital, pentobarbital,

 

21  or any salt thereof in combination with itself, with another, or

 

22  with 1 or more other controlled substances.

 

23        (e) Marihuana, but only for the purpose of treating a

 

24  debilitating medical condition as that term is defined in section

 

25  3(b) of the Michigan medical marihuana act, 2008 IL 1, MCL

 

26  333.26423, and as authorized under this act.

 

27        (f) Any material, compound, mixture, or preparation

 


 1  containing limited quantities of any of the following narcotic

 

 2  drugs or their salts:

 

 3        (i) Not more than 300 milligrams of dihydrocodeinone, or any

 

 4  of its salts, per 100 milliliters or not more than 15 milligrams

 

 5  per dosage unit, with a fourfold or greater quantity of an

 

 6  isoquinoline alkaloid of opium.

 

 7        (ii) Not more than 300 milligrams of dihydrocodeinone, or any

 

 8  of its salts, per 100 milliliters or not more than 15 milligrams

 

 9  per dosage unit, with 1 or more active nonnarcotic ingredients in

 

10  recognized therapeutic amounts.

 

11        (iii) Not more than 1.8 grams of dihydrocodeine, or any of its

 

12  salts, per 100 milliliters or not more than 90 milligrams per

 

13  dosage unit, with 1 or more active nonnarcotic ingredients in

 

14  recognized therapeutic amounts.

 

15        Sec. 7216. (1) The following controlled substances are

 

16  included in schedule 3:

 

17        (a) Unless listed in another schedule, any material,

 

18  compound, mixture, or preparation containing any quantity of the

 

19  following substances having a potential for abuse associated with

 

20  a stimulant effect on the central nervous system, including their

 

21  salts, isomers, including optical, position, or geometric

 

22  isomers, and salts of the isomers if the existence of the salts,

 

23  isomers, and salts of isomers is possible within the specific

 

24  chemical designation:

 

 

25

     Benzphetamine

     Mediatric tabs

26

     Chlorphentermine

     Mediatric liquid


1

     Clortermine

     Phendimetrazine

2

     Edrisal tabs

     Special formula 711 tabs

3

     Genegesic caps

     Thora Dex No. 1 tab

4

     Hovizyme tabs

     Thora Dex No. 2 tab

5

     Mazindol

 

 

 

 6        (b) Unless listed in another schedule, any material,

 

 7  compound, mixture, or preparation containing any quantity of the

 

 8  following substances having a potential for abuse associated with

 

 9  a depressant effect on the central nervous system, including

 

10  their salts, isomers, including optical, position, or geometric

 

11  isomers, and salts of the isomers if the existence of the salts,

 

12  isomers, and salts of isomers is possible within the specific

 

13  chemical designation:

 

 

14

     Chlorhexadol

     Phencyclidine

15

     Glutethimide

     Sulfondiethylmethane

16

     Lysergic acid

     Sulfonethylmethane

17

     Lysergix acid amide

     Sulfonmethane

18

     Methyprylon

 

 

 

19        (c) Nalorphine.

 

20        (d) Any substance that contains any quantity of a derivative

 

21  of barbituric acid, or any salt of a derivative of barbituric

 

22  acid, except those substances that are specifically listed in

 

23  other schedules.

 

24        (e) A compound, mixture, or preparation containing

 

25  amobarbital, secobarbital, pentobarbital, or a salt of

 


 1  amobarbital, secobarbital, or pentobarbital, and 1 or more other

 

 2  active medicinal ingredients that are not listed in a schedule.

 

 3        (f) A suppository dosage form containing amobarbital,

 

 4  secobarbital, pentobarbital, or a salt of amobarbital,

 

 5  secobarbital, or pentobarbital and approved by the food and drug

 

 6  administration for marketing only as a suppository.

 

 7        (g) Any material, compound, mixture, or preparation

 

 8  containing limited quantities of any of the following narcotic

 

 9  drugs or their salts:

 

10        (i) Not more than 1.8 grams of codeine, or any of its salts,

 

11  per 100 milliliters or not more than 90 milligrams per dosage

 

12  unit, with an equal or greater quantity of an isoquinoline

 

13  alkaloid of opium.

 

14        (ii) Not more than 1.8 grams of codeine, or any of its salts,

 

15  per 100 milliliters or not more than 90 milligrams per dosage

 

16  unit, with 1 or more active nonnarcotic ingredients in recognized

 

17  therapeutic amounts.

 

18        (iii) Not more than 300 milligrams of dihydrocodeinone, or any

 

19  of its salts, per 100 milliliters or not more than 15 milligrams

 

20  per dosage unit, with a fourfold or greater quantity of an

 

21  isoquinoline alkaloid of opium.

 

22        (iv) Not more than 300 milligrams of dihydrocodeinone, or any

 

23  of its salts, per 100 milliliters or not more than 15 milligrams

 

24  per dosage unit, with 1 or more active nonnarcotic ingredients in

 

25  recognized therapeutic amounts.

 

26        (v) Not more than 1.8 grams of dihydrocodeine, or any of its

 

27  salts, per 100 milliliters or not more than 90 milligrams per

 


 1  dosage unit, with 1 or more active nonnarcotic ingredients in

 

 2  recognized therapeutic amounts.

 

 3        (iii) (vi) Not more than 300 milligrams of ethylmorphine, or

 

 4  any of its salts, per 100 milliliters or not more than 15

 

 5  milligrams per dosage unit, with 1 or more ingredients in

 

 6  recognized therapeutic amounts.

 

 7        (iv) (vii) Not more than 500 milligrams of opium per 100

 

 8  milliliters or per 100 grams, or not more than 25 milligrams per

 

 9  dosage unit, with 1 or more active nonnarcotic ingredients in

 

10  recognized therapeutic amounts.

 

11        (v) (viii) Not more than 50 milligrams of morphine, or any of

 

12  its salts, per 100 milliliters or per 100 grams, with 1 or more

 

13  active nonnarcotic ingredients in recognized therapeutic amounts.

 

14        (h) Any material, compound, mixture, or preparation

 

15  containing any quantity of ketamine, a salt of ketamine, an

 

16  isomer of ketamine, or a salt of an isomer of ketamine.

 

17        (2) The administrator may promulgate rules to except a

 

18  compound, mixture, or preparation containing any stimulant or

 

19  depressant substance listed in subsection (1)(a) and or (b) from

 

20  the application of all or any part of this article if the

 

21  compound, mixture, or preparation contains 1 or more active

 

22  medicinal ingredients not having a stimulant or depressant effect

 

23  on the central nervous system and if the admixtures are in

 

24  combinations, quantity, proportion, or concentration that vitiate

 

25  the potential for abuse of the substances having a stimulant or

 

26  depressant effect on the central nervous system.